SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies

被引：3
|
作者：
Ryan, Maureen C. [1 ]
Schimpf, Brian [1 ]
Anderson, Martha [1 ]
Zeng, Weiping [1 ]
Emmerton, Kim [1 ]
Miyamoto, Jamie [1 ]
Kostner, Heather [1 ]
Yu, Changpu [1 ]
Van Epps, Heather [1 ]
Tatalick, Laurie [1 ]
Benjamin, Dennis [1 ]
机构：
[1] Seattle Genet Inc, Translat Res, Bothell, WA USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.594.594
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    Kochenderfer, James N.
    Rosenberg, Steven A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) : 267 - 276
  • [42] INITIAL EXPERIENCE WITH TREATMENT OF HUMAN B-CELL LYMPHOMA WITH ANTI-CD19 MONOCLONAL-ANTIBODY
    HEKMAN, A
    HONSELAAR, A
    VUIST, WMJ
    SEIN, JJ
    RODENHUIS, S
    HUININK, WWT
    SOMERS, R
    RUMKE, P
    MELIEF, CJM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 32 (06) : 364 - 372
  • [43] TREATMENT OF PATIENTS WITH B-CELLS MALIGNANCIES WITH ANTI-CD19 MONOCLONAL-ANTIBODIES
    HONSELAAR, A
    HEKMAN, A
    SEIN, J
    VROOM, T
    ISRAELS, S
    SOMERS, R
    TENBOKKEL, W
    RUMKE, P
    MEIEF, C
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 315 - 315
  • [44] In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies
    Zhiqiang Song
    Ping Liu
    Dongliang Zhang
    Tao Wang
    Wenqin Yue
    Yuke Geng
    Na Liu
    Yang Wang
    Jianmin Yang
    Blood Cancer Journal, 14
  • [45] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    James N. Kochenderfer
    Steven A. Rosenberg
    Nature Reviews Clinical Oncology, 2013, 10 : 267 - 276
  • [46] Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
    Abramson, Jeremy S.
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 29 - 33
  • [47] In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies
    Song, Zhiqiang
    Liu, Ping
    Zhang, Dongliang
    Wang, Tao
    Yue, Wenqin
    Geng, Yuke
    Liu, Na
    Wang, Yang
    Yang, Jianmin
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [48] Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts
    Jones, Luke
    McCalmont, Hannah
    Evans, Kathryn
    Mayoh, Chelsea
    Kurmasheva, Raushan T.
    Billups, Catherine A.
    Houghton, Peter J.
    Smith, Malcolm A.
    Lock, Richard B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [49] Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
    Liu, Xiao-Yun
    Pop, Laurentiu M.
    Tsai, Lydia
    Pop, Iliodora V.
    Vitetta, Ellen S.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (02) : 497 - 506
  • [50] Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies
    Ma, D
    McDevitt, MR
    Barendswaard, E
    Lai, L
    Curcio, MJ
    Pellegrini, V
    Brechbiel, MW
    Scheinberg, DA
    LEUKEMIA, 2002, 16 (01) : 60 - 66
12345